A governance framework for development and assessment of national action plans on antimicrobial resistance

被引:66
作者
Anderson, Michael [1 ]
Schulze, Kai [1 ,2 ]
Cassini, Alessandro [3 ]
Plachouras, Diamantis [3 ]
Mossialos, Elias [1 ]
机构
[1] London Sch Econ & Polit Sci, Dept Hlth Policy, London WC2A 2AE, England
[2] Univ Cambridge, MRC Epidemiol Unit, Cambridge, England
[3] European Ctr Dis Prevent & Control, Solna, Sweden
关键词
MIDDLE-INCOME COUNTRIES; ANTIBIOTIC-RESISTANCE; HEALTH SYSTEMS; STEWARDSHIP; STRATEGIES; INFECTION; POLICY; INTERVENTIONS; CHALLENGES; MANAGEMENT;
D O I
10.1016/S1473-3099(19)30415-3
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Strengthening governance is an essential strategy to tackling antimicrobial resistance (AMR) at all levels: global, national, regional, and local. To date, no systematic approach to governance of national action plans on AMR exists. To address this issue, we aimed to develop the first governance framework to offer guidance for both the development and assessment of national action plans on AMR. We reviewed health system governance framework reviews to inform the basic structure of our framework, international guidance documents from WHO, the Food and Agriculture Organization, the World Organisation for Animal Health, and the European Commission, and sought the input of 25 experts from international organisations, government ministries, policy institutes, and academic institutions to develop and refine our framework. The framework consists of 18 domains with 52 indicators that are contained within three governance areas: policy design, implementation tools, and monitoring and evaluation. To consider the dynamic nature of AMR, the framework is conceptualised as a cyclical process, which is responsive to the context and allows for continuous improvement and adaptation of national action plans on AMR.
引用
收藏
页码:E371 / E384
页数:14
相关论文
共 88 条
[1]   Global implementation of WHO's multimodal strategy for improvement of hand hygiene: a quasi-experimental study [J].
Allegranzi, Benedetta ;
Gayet-Ageron, Angele ;
Damani, Nizam ;
Bengaly, Loseni ;
McLaws, Mary-Louise ;
Moro, Maria-Luisa ;
Memish, Ziad ;
Urroz, Orlando ;
Richet, Herve ;
Storr, Julie ;
Donaldson, Liam ;
Pittet, Didier .
LANCET INFECTIOUS DISEASES, 2013, 13 (10) :843-851
[2]   Finding alternatives to antibiotics [J].
Allen, Heather K. ;
Trachsel, Julian ;
Looft, Torey ;
Casey, Thomas A. .
ANTIMICROBIAL THERAPEUTICS REVIEWS: INFECTIOUS DISEASES OF CURRENT AND EMERGING CONCERN, 2014, 1323 :91-100
[3]   What are the public health effects of direct-to-consumer drug advertising? [J].
Almasi, EA ;
Stafford, RS ;
Kravitz, RL ;
Mansfield, PR .
PLOS MEDICINE, 2006, 3 (03) :284-288
[4]   Out-of-pocket health expenditures and antimicrobial resistance in low-income and middle-income countries: an economic analysis [J].
Alsan, Marcella ;
Schoemaker, Lena ;
Eggleston, Karen ;
Kammili, Nagamani ;
Kolli, Prasanthi ;
Bhattacharya, Jay .
LANCET INFECTIOUS DISEASES, 2015, 15 (10) :1203-1210
[5]  
Altorf-van der Kuil W, 2017, EUROSURVEILLANCE, V22, P22
[6]  
[Anonymous], 2016, Scientific Roadmap for Antibiotic Discovery Pew Charitable Trusts
[7]  
[Anonymous], 2003, POLICY BRIEF
[8]  
[Anonymous], 2016, TACKLING DRUG RESIST
[9]  
[Anonymous], 2016, PRUD US ANT AG HUM M
[10]  
[Anonymous], 1997, GOVERNANCE SUSTAINAB